These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24141347)

  • 1. A FRAX model for the estimation of osteoporotic fracture probability in Portugal.
    Marques A; Mota A; Canhão H; Romeu JC; Machado P; Ruano A; Barbosa AP; Dias AA; Silva D; Araújo D; Simões E; Aguas F; Rosendo I; Silva I; Crespo J; Alves JD; Costa L; Mascarenhas M; Lourenço Ó; Ferreira PL; Lucas R; Roque R; Branco JC; Tavares V; Johansson H; Kanis J; Pereira da Silva JA
    Acta Reumatol Port; 2013; 38(2):104-12. PubMed ID: 24141347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures.
    Lalmohamed A; Welsing PM; Lems WF; Jacobs JW; Kanis JA; Johansson H; De Boer A; De Vries F
    Osteoporos Int; 2012 Mar; 23(3):861-9. PubMed ID: 22120910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of hip fracture in Brazil and the development of a FRAX model.
    Zerbini CA; Szejnfeld VL; Abergaria BH; McCloskey EV; Johansson H; Kanis JA
    Arch Osteoporos; 2015; 10():224. PubMed ID: 26303038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and application of FRAX in the management of osteoporosis in Ireland.
    McGowan B; Kanis JA; Johansson H; Silke C; Whelan B
    Arch Osteoporos; 2013; 8():146. PubMed ID: 23982943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of osteoporotic fracture in Kazakhstan and development of a country specific FRAX model.
    Issayeva S; Lesnyak O; Zakroyeva A; Issayeva B; Dilmanova D; Johansson H; Liu E; Lorentzon M; Harvey NC; McCloskey E; Kanis JA
    Arch Osteoporos; 2020 Feb; 15(1):30. PubMed ID: 32108270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.
    Leslie WD; Lix LM; Langsetmo L; Berger C; Goltzman D; Hanley DA; Adachi JD; Johansson H; Oden A; McCloskey E; Kanis JA
    Osteoporos Int; 2011 Mar; 22(3):817-27. PubMed ID: 21161509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of hip fracture in Romania and the development of a Romanian FRAX model.
    Grigorie D; Sucaliuc A; Johansson H; Kanis JA; McCloskey E
    Calcif Tissue Int; 2013 May; 92(5):429-36. PubMed ID: 23334302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of hip fracture in Belarus: development of a country-specific FRAX model and its comparison to neighboring country models.
    Ramanau H; Chernyanin I; Rudenka E; Lesnyak O; Zakroyeva A; Bilezikian JP; Johansson H; Harvey NC; McCloskey EV; Kanis JA
    Arch Osteoporos; 2018 Apr; 13(1):42. PubMed ID: 29666948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FRAX® probabilities and risk of major osteoporotic fracture in France.
    Couris CM; Chapurlat RD; Kanis JA; Johansson H; Burlet N; Delmas PD; Schott AM
    Osteoporos Int; 2012 Sep; 23(9):2321-7. PubMed ID: 22179418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of hip fracture in Barranquilla, Colombia, and the development of a Colombian FRAX model.
    Jaller-Raad JJ; Jaller-Char JJ; Lechuga-Ortiz JA; Navarro-Lechuga E; Johansson H; Kanis JA
    Calcif Tissue Int; 2013 Jul; 93(1):15-22. PubMed ID: 23471427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women.
    Leslie WD; Brennan SL; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
    Arch Osteoporos; 2013; 8():145. PubMed ID: 23929269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated fracture incidence rates for the Italian version of FRAX®.
    Piscitelli P; Chitano G; Johannson H; Brandi ML; Kanis JA; Black DM
    Osteoporos Int; 2013 Mar; 24(3):859-66. PubMed ID: 22638710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale of the Spanish FRAX model in decision-making for predicting osteoporotic fractures: an update of FRIDEX cohort of Spanish women.
    Azagra R; Zwart M; Encabo G; Aguyé A; Martin-Sánchez JC; Puchol-Ruiz N; Gabriel-Escoda P; Ortiz-Alinque S; Gené E; Iglesias M; Moriña D; Diaz-Herrera MA; Utzet M; Manresa JM;
    BMC Musculoskelet Disord; 2016 Jun; 17():262. PubMed ID: 27317560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the risk of osteoporotic fractures: the Ecuadorian FRAX model.
    Lopez Gavilanez E; Johansson H; McCloskey E; Harvey NC; Segale Bajana A; Marriott Blum D; Navarro Grijalva M; Diaz Curiel M; Kanis JA
    Arch Osteoporos; 2019 Aug; 14(1):93. PubMed ID: 31440846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of hip fractures in Bulgaria: development of a country-specific FRAX model.
    Kirilova E; Johansson H; Kirilov N; Vladeva S; Petranova T; Kolarov Z; Liu E; Lorentzon M; Vandenput L; Harvey NC; McCloskey E; Kanis JA
    Arch Osteoporos; 2020 Feb; 15(1):28. PubMed ID: 32108268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FRAX-based Estimates of 10-year Probability of Hip and Major Osteoporotic Fracture Among Adults Aged 40 and Over: United States, 2013 and 2014.
    Looker AC; Sarafrazi Isfahani N; Fan B; Shepherd JA
    Natl Health Stat Report; 2017 Mar; (103):1-16. PubMed ID: 28459415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of hip fracture and the development of FRAX in Ukraine.
    Povoroznyuk VV; Grygorieva NV; Kanis JA; Ev M; Johansson H; Harvey NC; Korzh MO; Strafun SS; Vaida VM; Klymovytsky FV; Vlasenko RO; Forosenko VS
    Arch Osteoporos; 2017 Dec; 12(1):53. PubMed ID: 28567714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of osteoporotic fracture in Moldova and development of a country-specific FRAX model.
    Zakroyeva A; Lesnyak O; Cazac V; Groppa L; Russu E; Chislari L; Rotaru L; Johansson H; Harvey NC; McCloskey E; Lorentzon M; Kanis JA
    Arch Osteoporos; 2020 Jan; 15(1):13. PubMed ID: 31993755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of changes in mortality on FRAX-derived fracture probabilities.
    Kreidieh OI; El-Hajj Fuleihan G
    Bone; 2014 May; 62():43-50. PubMed ID: 24480305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of a FRAX revision for the USA.
    Kanis JA; Johansson H; Oden A; Dawson-Hughes B; Melton LJ; McCloskey EV
    Osteoporos Int; 2010 Jan; 21(1):35-40. PubMed ID: 19705047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.